跳至主要内容
临床试验/CTRI/2020/04/024624
CTRI/2020/04/024624招募中4 期

Prospective, observational, multi-centre, post marketing surveillance tomeasure the effectiveness of Omeprazole on patient reported outcomemeasures in acid peptic disease

Dr Reddys Laboratories Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Subjects must voluntarily give consent in writing to participate in the
  • study by signing the Informed Consent Form (ICF)
  • 2. Subjects of either sex diagnosed with acid peptic disease aged >=18
  • years and <=65 years.
  • 3. Subject who has been prescribed omeprazole therapy as routine
  • clinical management as per Investigator discretion.

排除标准

  • 1. Hyper-sensitivity to any Proton pump inhibitor including omeprazole
  • in the past.
  • 2. Participated in an investigational drug or investigational device study
  • within 30 days prior to the start of the study
  • 3. Prior treatment for acid peptic disease histamine-2 receptor
  • antagonists or over the counter antacids during the week immediately
  • before the study
  • 4. Any medical condition according to investigator which may interfere
  • with the treatment. Makes patient illegible for participation in study.
  • 5. Planned surgical procedure during the duration of the study.
  • 6. Women who are pregnant or breast-feeding and women who could
  • become pregnant during the study

研究者

相似试验